Table 4.
Patient Group | All Patients | IL-1 Genotype Positive | IL-1 Genotype Negative | ||||||
---|---|---|---|---|---|---|---|---|---|
All ages | Total No. | No. with CAD (%) | OR (95% CI) | Tot al No. | No. with CAD (%) | OR (95% CI) | Total N | No. with CAD (%) | OR (95% CI) |
Quartile I | 125 | 55 (44) | 1.00 | 70 | 30 (43) | 1.00 | 55 | 25 (46) | 1.00 |
Quartile II | 125 | 62 (50) | 1.25 (0.76–2.06) | 77 | 37 (48) | 1.23 (0.64–2.37) | 48 | 25 (52) | 1.30 (0.60–2.83) |
Quartile III | 125 | 68 (54) | 1.52 (0.92–2.50) | 84 | 42 (50) | 1.33 (0.70–2.52) | 41 | 26 (63) | 2.08 (0.91–4.76) |
Quartile IV | 124 | 83 (67) | 2.58(1.54–4.31) | 68 | 51 (75) | 4.00 (1.94–8.26) | 56 | 32 (57) | 1.60 (0.76–3.39) |
OR (95%CI) for trend | 1.35 (1.15–1.59) | 1.49 (1.20–1.85) | 1.20 (0.94–1.52) | ||||||
P for trend | <0.001 | <0.001 | 0.14 | ||||||
Age >60 yr | |||||||||
Quartile I | 65 | 38 (58) | 1.00 | 38 | 22 (58) | 1.00 | 27 | 15 (56) | 1.00 |
Quartile II | 68 | 43 (62) | 1.30 (0.65–2.61) | 41 | 27 (66) | 1.40 (0.56–3.49) | 27 | 16 (59) | 1.16 (0.40–3.42) |
Quartile III | 67 | 42 (61) | 1.21 (0.56–2.24) | 40 | 23 (58) | 0.98 (0.40–2.42) | 27 | 17 (63) | 1.36 (0.46–4.04) |
Quartile IV | 60 | 44 (72) | 2.08 (0.98–4.42) | 32 | 24 (75) | 2.18 (0.78–6.09) | 28 | 20 (71) | 2.00 (0.65–6.11) |
OR (95%CI) for trend | 1.21 (0.96–1.53) | 1.19 (0.87–1.62) | 1.25 (0.88–1.77) | ||||||
P for trend | P=0.10 | P=0.27 | P=0.22 |